oviarin cancer
Conditions
Interventions
Medication group: The patients took 6 – 8 tablets of RIF TID, orally for one month, every other month, and then took the next course of oral treatment. Patients received 3 or more courses of treatment
Sponsors
Peking University People's Hospital
Eligibility
Sex/Gender
Female
Age
20 Years to 80 Years
Inclusion criteria
Inclusion criteria: all patients with ovarian epithelial cancer attending our Hospital who received standard chemotherapy and achieved complete remission. The patients took 6 – 8 tablets of RIF TID, orally for one month, every other month, and then took the next course of oral treatment. Patients received 3 or more courses of treatment.
Exclusion criteria
Exclusion criteria: Non-ovarian epithelial cancer Did not use compound Huangdai tablet for maintenance treatment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| progression-free interval ;overall survival ; | — |
Countries
China
Contacts
Public ContactXiaoping Li
Peking University People's Hospital
Outcome results
None listed